期刊文献+

培哚普利治疗高血压患者左室舒张功能的疗效 被引量:2

Effect of perindopril on left ventricular diastolic function in patients with essential hypertension
下载PDF
导出
摘要 目的:观察培哚普利对原发性高血压(EH)患者左心室舒张功能的影响。方法:采用自身对照开放试验方法,观察50例EH患者培哚普利治疗6月后,左心室舒张内径(LVDd)、舒张期室间隔厚度(IVST)、舒张末期左心室后壁厚度(LVPWT)、左心室重量指数(LVMI)、二尖瓣口E峰、A峰、A/E比值的变化。结果:50例EH患者治疗6个月后,IVST、LVPWT、LVMI明显下降(P<0.05),A峰、A/E比值亦明显下降(P<0.05)。结论:培哚普利在降压的同时,不但能逆转左心室肥厚,并且能有效改善左心室舒张功能。 Objective: To study the effect of perindopril on left ventricular diastolic function in patients with essential hypertension (EH). Methods: A self control, open clinical trial was carried out to observe the effect of perindopril of left ventricular diastolic function in patients with EH. Ultrasonic scanning and mitral blood speed analysis were performed in all 50 patients and results were compared before and after 6 months treatment. Results: After 6 months treatment with perindopril (4 mg/d or 8 mg/d), ultrasonic scanning comparison indicated that IVST. LVPWT. LVMI significantly lowered (P<0.05), VA and A/E ratio significantly decreased (P<0.05). Conclusion: Perindopril can not only decrease blood pressure, but also can improve left ventricular diastolic function and decrease left ventricular hypertrophy at the same time.
出处 《心血管康复医学杂志》 CAS 2004年第3期242-244,共3页 Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词 培哚普利 药物治疗 高血压 左室舒张功能 Essential hypertention Perindopril Diastolic function left ventricle
  • 相关文献

参考文献1

  • 1[1]Schmieder RE, Martus P. Reversal of left ventricular hypertropny in essential hypertension: A meta-analysis of randomized double blind sturdies [J]. JAMA, 1996, 275: 1507.

同被引文献23

  • 1王魁晶,古欣,王静,滕力明,任春梅.吲哒帕胺对原发性高血压患者TXA_2、PGI_2含量的影响[J].心血管康复医学杂志,2004,13(6):557-559. 被引量:3
  • 2王华梁,陈思聪,张国元,朱绍荣,王笑利,孔宪涛,许绍辉,徐莲芳.双抗夹心法检测血浆氧化修饰型低密度脂蛋白[J].上海医学检验杂志,1994,9(3):135-136. 被引量:33
  • 3Schillaei G, Pasqualini L, Verdecchia P, et al. Prognostic significance of left ventrieular diastolic dysfunction in essential hypertension [J]. J Am Coll Cardiol, 2002, 39 (12): 2005-2011.
  • 4Schmieder RE, Martus P, Klingbeil A, et al. Reversal of left ventricular hypertrophy in essential hypertension: A meta analysis of randomized double blind study [J]. JAMA, 1996, 275: 1507-1513.
  • 5Maisel A, Koon J, Krishnaswamy P, et al. Utility of B-natriuretlc peptide as a rapid point-of-care test for screening patients undergoing echoeardiography to detennlne left ventricular dysfunction [J]. Am Heart J, 2001, 141: 367-374.
  • 6Carcia MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function [J]. J Am Coll Cardiol, 1998, 32 (4): 865-875.
  • 7Devereux RB, Reichek N. Eehoeardiographie determination of left ventrieular mass in man: anatomic validation of the method [J]. Circulation, 1977, 55 (4): 613-618.
  • 8Dostal DE, Baker KM. Eivdenee for a role of an intracardiac renin angiorensin system in normal and failing hearts [J]. Trends CardiovascMed, 1993, 25: 63-67.
  • 9Wagstaff AJ, Davis R, McTavish D. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension [J]. Drugs, 1996, 51 (5): 777.
  • 10Anan F, Takahashi N, Oole T, et al. Candesartan, an angiotensin Ⅱ receptor blocker, improves left ventrieular hypertrophy and insulin resistanee [J]. Metabolism, 2004 Jun, 53 (6): 777-781.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部